United States · biotech/health

Karuna Therapeutics

Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.

Public · NASDAQ:KRTXFor profit

biotech/healthUnited States

Against its peers

Set against 435 biotech/health companies in United States. The ring marks the typical peer.

Staff251-500Larger than the typical peer (11-50)
Founded20096 years before the typical peer (2015)
Website traffic#948kBusier than the typical peer's site (#4.2M)

Across all 5.9M companies: larger than 92% of those with a size listed; older than 40% of those with a founding year; website ranked #948,321 in the world, about 29k visits a month.

About Karuna Therapeutics

What it does

BiopharmaHealth CareTherapeutics

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$1.6B

raised in total, currency not stated across 7 rounds

Last raised Mar 2023, 3 years ago

Rounds
7
Latest round
Post ipo equity
Investors
112 leading

Key facts

Who started it and how it trades.

Founded by
Andrew Miller

Every detail we hold

Everything the source datasets list about Karuna Therapeutics, field by field. Contact details are held but never shown.

The company7 fields

Name
Karuna Therapeutics
Type
For profit
Status
Public · NASDAQ:KRTX
Founded
2009
Founders
Andrew Miller
Industry
biotech/health
Categories
Biopharma, Health Care, Therapeutics

Where2 fields

Country
United States
Markets
Greater Boston Area, East Coast, New England, Northeastern US

Size and reach3 fields

Staff band
251-500
Web traffic rank
#948,321
Monthly web visits
29,342
Show 10 more fieldsShow fewer fields

Funding, as listed8 fields

Total
1,598,600,000 (currency not stated)
Rounds
7
Latest round
Post ipo equity
Latest round date
Mar 2023
Investors
11
Lead investors
2
Stock listing
NASDAQ:KRTX
Listing status
public

About this record2 fields

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Karuna Therapeutics was acquired by Bristol Myers Squibb, which strengthened its neuroscience portfolio. Following the acquisition announcement, Karuna Therapeutics saw a rise in its stock price.

Companies like Karuna Therapeutics

biotech/health in United States.

Build a lead list

435 biotech/health companies in United States, filtered by size, age and reach, ready to export with emails on Pro.

Open the list